Harrison Seth Loring

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Harrison Seth Loring
CIK #0001404955
EDGAR Form CIK 2011 - 2026
3 [0001404955]
4 [0001404955]
Form 3/4/5 Subject 2011 - 2026
Stoke Therapeutics Inc
Harrison Seth Loring
Akero Therapeutics Inc
ATP Life Science Ventures LP
ATP III GP Ltd
HeartWare International Inc
Tokai Pharmaceuticals Inc
Avalo Therapeutics Inc
Titan Pharmaceuticals Inc
Apple Tree Consolidated BVBA SPRL
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Akero Therapeutics Inc AKRO
Common Stock
2025-12-09 Disposed to issuer 136,301
Akero Therapeutics Inc AKRO
Common Stock
2025-12-09 Disposed to issuer 148,063
Akero Therapeutics Inc AKRO
Common Stock
2025-12-09 Disposed to issuer 9,398
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
2025-12-09 Disposed to issuer 13,000
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
2025-12-09 Disposed to issuer 15,000
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
2025-12-09 Disposed to issuer 13,000
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
2025-12-09 Disposed to issuer 15,000
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
2025-12-09 Disposed to issuer 26,000
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
2025-12-09 Disposed to issuer 26,000
Akero Therapeutics Inc AKRO
Common Stock
2025-06-03 Grant 9,398 $0.00
Stoke Therapeutics Inc STOK
Director Stock Option (Right to Buy) · derivative
2025-06-03 Grant 29,747 $0.00
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
2024-06-08 Grant 26,000 $0.00
Stoke Therapeutics Inc STOK
Director Stock Option (Right to Buy) · derivative
2024-06-05 Grant 7,639 $0.00
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
2023-06-23 Grant 15,000 $0.00
Stoke Therapeutics Inc STOK
Director Stock Option (Right to Buy) · derivative
2023-06-13 Grant 19,441 $0.00
Akero Therapeutics Inc AKRO
Common Stock
2022-11-30 Sell 6,851 $46.44 318,160
Akero Therapeutics Inc AKRO
Common Stock
2022-11-30 Sell 5,179 $47.60 246,520
Akero Therapeutics Inc AKRO
Common Stock
2022-11-30 Sell 6,322 $46.44 293,594
Akero Therapeutics Inc AKRO
Common Stock
2022-11-30 Sell 4,779 $47.60 227,480
Akero Therapeutics Inc AKRO
Common Stock
2022-10-28 Sell 800 $41.12 32,896
showing 20 of 175 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com